Patents by Inventor Jeffrey Harris Baxter

Jeffrey Harris Baxter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NUTRITIONAL PRODUCTS HAVING IMPROVED ORGANOLEPTIC PROPERTIES
    Publication number: 20130243904
    Abstract: Disclosed are nutritional products comprising pea protein hydrolysates as a primary or sole source of protein. The nutritional products include nutritional liquids, powders, bars, and other food products, wherein the resulting nutritional products are physically stable over shelf life and provide favorable organoleptic properties. These nutritional products may be used as a nutritional source for individuals who are intolerant and/or allergic to cow milk proteins and soy proteins and/or who have malabsorption, maldigestion, or other gastroinstestinal conditions.
    Type: Application
    Filed: August 22, 2011
    Publication date: September 19, 2013
    Applicant: ABBOTT LABORATORIES
    Inventors: Christopher T. Cordle, Steven T. Luebbers, Larry W. Williams, Jeffrey Harris Baxter, Geralyn Duska-Mcewen
  • Phosphorylated recombinant human .beta.-casein expressed in a bacterial system
    Patent number: 5942254
    Abstract: The present invention provides a plasmid containing a promoter sequence, a nucleotide sequence encoding an exogenous protein, and a nucleotide sequence encoding an enzyme capable of modifying the exogenous protein. In a specific embodiment of the invention the encoded exogenous protein is human .beta.-casein and the encoded enzyme is a human kinase capable of phosphorylating recombinant .beta.-casein in a bacterial system. Phosphorylated recombinant human .beta.-casein synthesized using the plasmid of the invention is shown to have the same bioactivity as native human .beta.-casein.
    Type: Grant
    Filed: November 6, 1995
    Date of Patent: August 24, 1999
    Assignee: Abbott Laboratories
    Inventors: Pradip Mukerji, Jennifer Marie Thurmond, Lennart Hansson, Jeffrey Harris Baxter, Robert George Hards
  • Method for expressing phosphorylated recombinant human .beta.-casein in a bacterial system
    Patent number: 5807702
    Abstract: The present invention provides a method of producing phophorylated, recombinant human .beta.-casein having 3 to 5 phosphates in a bacterial cell using a single vector containing in tandem both the nucleotide sequence encoding .beta.-casein and a sequence encoding the enzyme CKII .beta..alpha. which is capable of phosphorylating human .beta.-casein.
    Type: Grant
    Filed: November 6, 1995
    Date of Patent: September 15, 1998
    Assignee: Abbott Laboratories
    Inventors: Pradip Mukerji, Jennifer Marie Thurmond, Lennart Hansson, Jeffrey Harris Baxter, Robert George Hards
  • Product for inhibition of human rotavirus infection
    Patent number: 5712250
    Abstract: An enteral nutritional product containing either bovine .kappa.-casein or human .kappa.-casein at a concentration greater than that found in human or bovine milk and sufficient to inhibit infection of mammalian cells by human rotavirus.
    Type: Grant
    Filed: October 15, 1996
    Date of Patent: January 27, 1998
    Assignees: Abbott Laboratories, University of Oklahoma
    Inventors: Pradip Mukerji, Pedro Antonio Prieto, Amanda Eun-Yeong Seo, Jeffrey Harris Baxter, Richard Dale Cummings
  • Plasmid for expressing phosphorylated recombinant proteins in a bacterial system
    Patent number: 5710044
    Abstract: The present invention provides a plasmid containing a promoter sequence, a nucleotide sequence encoding an exogenous protein, and a nucleotide sequence encoding an enzyme capable of modifying the exogenous protein. In a specific embodiment of the invention the encoded exogenous protein is human .beta.-casein and the encoded enzyme is a human kinase capable of phosphorylating recombinant .beta.-casein in a bacterial system. Phosphorylated recombinant human .beta.-casein having 3 or more phosphate groups and synthesized using the plasmid of the invention is shown to have the same bioactivity as native human .beta.-casein.
    Type: Grant
    Filed: November 6, 1995
    Date of Patent: January 20, 1998
    Assignee: Abbott Laboratories
    Inventors: Pradip Mukerji, Jennifer Marie Thurmond, Lennart Hansson, Jeffrey Harris Baxter, Robert George Hards